3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
4Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymerbased paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial [ J ]. JAMA, 2005, 294(10) : 1215 - 1223.
5Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions [ J ]. Circulation, 2004, 109 ( 10 ) : 1244 - 1249.
6Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term resuits of drug-eluting stent implantation in unprotected left main[ J]. Circulation, 2005, 111 (6) :791 - 795.
7Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease [ J ]. N Engl J Med, 2004, 350(3) :221 -231.
8Iakovou I, Schmidt T, Ge L, et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation[ J]. J Am Coll Cardiol, 2005, 45(5) :805 -806.
9Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus-or paclitaxel-eluting stents [J]. Circulation, 2006, 113(19) :2293 -2300.
10Lee CW, Park DK, Lee BK, et al. Predictors of restenosis after placement of drug-eluting Stents in one or more coronary arteries [J]. Am J Cardiol, 2006, 97(4) :506 -511.
